Unlike what was observed upon GSR loss, we found that deleting TXNRD1 had no impact on tumor number (tumor initiation) in the KrasG12D/+, Nrf2+/+ or KrasG12D/+, Nrf2D29H/+ mice (Fig. 3C and D). The gene discussed is TXNRD1; the disease is neoplasm.